Chlamydia trachomatis: Serovars, Life Cycle, Diseases, Diagnosis, Treatment

A 22-year-old woman comes in for a routine check. She feels completely well and has no symptoms. A screening test of her urine comes back positive for Chlamydia trachomatis. She is surprised, because nothing hurt and nothing looked wrong. That silence is exactly the problem.

In many women this infection causes no symptoms for months while it quietly spreads up the genital tract, where it can scar the fallopian tubes and threaten future fertility. The organism is hard to notice for the same reason it is hard to grow in the lab: it hides and multiplies inside the patient's own cells. This is Chlamydia trachomatis, the most common bacterial cause of sexually transmitted infection.

Introduction

Chlamydia trachomatis is an obligate intracellular bacterium and a major cause of disease worldwide. It is the most common bacterial cause of sexually transmitted infection and a leading cause of preventable infertility and of pelvic inflammatory disease (PID). It also causes trachoma, the world's leading infectious cause of blindness.

One idea organizes the whole topic: C. trachomatis has a unique two-form life cycle that forces it to live inside host cells, and this single feature explains why it does not Gram stain, why it cannot be grown on ordinary media, why diagnosis relies on detecting its DNA, and why certain antibiotics work while others fail.

General Properties

Small, non-motile, coccoid bacteria with a gram-negative-type cell envelope. However, the cell wall lacks a typical peptidoglycan layer and has little or no muramic acid, so C. trachomatis does not stain usefully with the Gram stain.

• Obligate intracellular bacterium: it cannot make its own energy efficiently (it depends on the host cell for ATP), so it can only grow inside host cells. Because it is so small and grows inside cells, it was once mistaken for a virus, but it is a true bacterium with both DNA and RNA, ribosomes, and a cell wall.

The two-form life cycle

Figure: Life Cycle of Chlamydia trachomatis

C. trachomatis alternates between two forms, and understanding this cycle explains almost everything about the organism.

• The elementary body (EB) is the small, tough, infectious form. It does not divide. Its only job is to survive outside cells and get into a new cell. This is the form transmitted from person to person.
• The reticulate body (RB) is the larger, fragile, metabolically active form. It does not spread between people. Its only job is to multiply inside the cell.

The cycle runs like this: an elementary body attaches to and enters a host cell, where it stays inside a membrane-bound vacuole called an inclusion. Inside the inclusion it transforms into a reticulate body, which multiplies many times by binary fission. The reticulate bodies then convert back into elementary bodies, and the cell releases them to infect new cells. The whole cycle takes about 48 to 72 hours. This is why chlamydial infections build up slowly and why the diagnostic "inclusions" seen in stained cells are collections of these organisms.

A note on classification: this article follows the exam-standard grouping in which Chlamydia includes C. trachomatis, C. psittaci, and C. pneumoniae (the TWAR strains). Be aware that modern taxonomy has at times placed C. psittaci and C. pneumoniae in a separate genus, Chlamydophila. The biology and the diseases are what matter for study; the genus label has shifted back and forth.

How Chlamydia trachomatis causes disease

The damage in chlamydial infection comes from two things: the organism's growth inside cells, and the host's inflammatory response to it.

Each cycle of growth kills the infected host cell when the new elementary bodies are released, causing direct tissue damage. But much of the serious, long-term harm comes from repeated and persistent inflammation. In the eye, repeated infection causes chronic conjunctival inflammation that scars the inner eyelid, turns the eyelashes inward, and abrades the cornea, eventually leading to blindness (trachoma).

In the female genital tract, ascending infection and the resulting inflammation scar the fallopian tubes. This tubal scarring is what causes infertility, ectopic pregnancy, and chronic pelvic pain, and it can develop even when the infection itself caused few or no symptoms. This "silent damage" is why screening is so important.

Diseases caused by C. trachomatis

The single most important thing to know about C. trachomatis is that different serovars (serotypes) cause different diseases. Learn the three groups and their diseases:

A simple way to hold this: A B C at the start of the alphabet = the eye disease that can blind (trachoma); D through K in the middle = the common genital and neonatal infections; L = the invasive Lymphatic disease (LGV).

Eye disease

• Trachoma (serovars A–C): a chronic infection of the conjunctiva spread in areas with poor sanitation. Repeated infection scars the eyelid, turns the lashes inward, and damages the cornea, and it is the world's leading infectious cause of blindness.
• Inclusion conjunctivitis (serovars D–K): a milder eye infection caused by genital serovars reaching the eye, either in a newborn during birth or in adults by autoinoculation from genital secretions. It usually heals without scarring.

Genital and related infections (serovars D–K)

• Nongonococcal urethritis
• Cervicitis
• Pelvic inflammatory disease (PID), a major cause, which can lead to infertility, ectopic pregnancy, and chronic pelvic pain
• Epididymitis and proctitis
• In newborns: inclusion conjunctivitis and infant pneumonia (acquired during birth)

A key clinical point: genital chlamydia is frequently asymptomatic, especially in women, which is why it spreads and why routine screening of at-risk groups is recommended.

Lymphogranuloma venereum (serovars L1–L3)

LGV is different from the D–K infections because the L serovars are more invasive: they spread to and multiply in lymphatic tissue. It classically causes swollen, sometimes painful inguinal lymph nodes (buboes), often after a small painless genital ulcer that may be missed. In recent years it has also caused proctitis, particularly in men who have sex with men.

A note on the respiratory Chlamydia species

Two related species mainly cause respiratory disease rather than the infections above. C. pneumoniae (TWAR) causes upper respiratory infection, bronchitis, and atypical pneumonia and spreads person to person. C. psittaci causes psittacosis, an atypical pneumonia caught from infected birds (parrots and others).

Route of transmission

a. Direct contact

• Primarily spread from human to human by sexual transmission: Genital infections
• From mother to infant during birth: Neonatal pneumonia or inclusion conjunctivitis

b. Respiratory route: C. psittaci and C. pneumoniae

Laboratory diagnosis of C. trachomatis infection

Because C. trachomatis lives inside cells and cannot be seen on a Gram stain or grown on ordinary media, laboratory diagnosis is built around detecting the organism's DNA. The methods, in order of current importance:

Nucleic acid amplification tests (NAAT): the first-line test

NAATs (such as PCR) detect C. trachomatis DNA and are the recommended first-line test today. They are the most sensitive and specific method, and, importantly, they can be run on samples that are easy to collect, including first-catch urine and self-collected vaginal swabs, which makes screening practical and acceptable. This is the test to remember.

Specimen

Scrapings from the eyes or urogenital tract, materials aspirated from epididymis, fallopian tubes, sera, tissue biopsy.

The Gram stain is not useful for C. trachomatis: the organisms are intracellular and the cell wall does not take the stain well.

Cytology

Cytologic examination of cell scrapings from the conjunctiva of newborns or persons with ocular trachoma by Giemsa staining. Inclusion bodies in scraped tissues can also be identified by iodine staining of glycogen present in the cytoplasmic vacuoles of infected cells and viewing under a microscope. Staining of C. trachomatis elementary bodies by fluorescent monoclonal antibodies.

Serodiagnosis

Serologic testing has limited value for diagnosing urogenital infections in adults because most adults with chlamydial infection have had previous exposure to C. trachomatis and are, therefore seropositive.  But negative serology can reliably exclude chlamydial infections.

Serology is more useful for LGV than for uncomplicated genital infection: a high complement-fixation antibody titer (for example, ≥1:64) supports a diagnosis of lymphogranuloma venereum. Detection of C. trachomatis specific IgM is useful in diagnosing neonatal infections.

In situ DNA hybridization with cloned C. trachomatis DNA probes in tissue biopsy specimens.

Cultivation/Culture

Culture is highly specific but is less sensitive than NAAT, and it is expensive, technically demanding, and needs careful specimen transport. It is now used mainly in special situations (for example, evaluating treatment failure or medico-legal cases such as suspected sexual assault). C. trachomatis is grown in cell lines such as cycloheximide-treated McCoy cells, HeLa cells, and monkey kidney cells, where it forms the characteristic intracellular inclusions.

Treatment of Chlamydia trachomatis infection

Treatment uses antibiotics that get inside host cells and act on protein synthesis, because the organism is intracellular. Beta-lactams are not reliable and are not used for chlamydia, which fits the pattern seen across intracellular organisms.

Genital infection. The current first-line treatment is doxycycline given for 7 days. This is a recent and important change: doxycycline is now preferred over single-dose azithromycin, because azithromycin has higher treatment-failure rates, especially for rectal infection. Azithromycin as a single dose is now an alternative, and it remains the preferred choice in pregnancy, where doxycycline is avoided.

Lymphogranuloma venereum (LGV). LGV needs a longer course of doxycycline than uncomplicated genital infection, because the infection is invasive and involves lymphatic tissue.

Newborns with chlamydial conjunctivitis or pneumonia are treated with an oral macrolide, not with topical eye treatment alone, because the organism also colonizes the nasopharynx.

Trachoma control uses azithromycin, often given to whole communities as part of public-health programs, alongside measures to improve hygiene and reduce transmission.

Two public-health essentials. First, sexual partners must be evaluated and treated, or the patient will simply be reinfected; many places allow expedited partner therapy for this. Second, because genital chlamydia is so often silent, screening of sexually active young women and other at-risk groups is a key strategy to prevent the tubal damage that causes infertility.

How to Remember

Key exam facts in one table

Where Students Get Confused

References

1. Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.
2. Carroll, K. C., Pfaller, M. A., et al. (2020). Murray's Medical Microbiology (9th ed.). Elsevier.
3. Workowski, K. A., Bachmann, L. H., Chan, P. A., et al. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1–187.
4. World Health Organization. Trachoma fact sheet. WHO (current version).